166 related articles for article (PubMed ID: 2202093)
1. European Stroke Prevention Study. ESPS Group.
Stroke; 1990 Aug; 21(8):1122-30. PubMed ID: 2202093
[TBL] [Abstract][Full Text] [Related]
2. The European Stroke Prevention Study (ESPS): results by arterial distribution.
Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
[TBL] [Abstract][Full Text] [Related]
3. The European Stroke Prevention Study: results according to sex.
Sivenius J; Laakso M; Penttilä IM; Smets P; Lowenthal A; Riekkinen PJ
Neurology; 1991 Aug; 41(8):1189-92. PubMed ID: 1866002
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European Stroke Prevention Study (ESPS).
Sivenius J; Riekkinen PJ; Kilpeläinen H; Laakso M; Penttilä I
Acta Neurol Scand; 1991 Oct; 84(4):286-90. PubMed ID: 1772001
[TBL] [Abstract][Full Text] [Related]
5. Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of stroke.
Redman AR; Ryan GJ
Clin Ther; 2001 Sep; 23(9):1391-408. PubMed ID: 11589255
[TBL] [Abstract][Full Text] [Related]
6. Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.
Sivenius J; Cunha L; Diener HC; Forbes C; Laakso M; Lowenthal A; Smets P; Riekkinen P
Acta Neurol Scand; 1999 Jan; 99(1):54-60. PubMed ID: 9925239
[TBL] [Abstract][Full Text] [Related]
7. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
8. Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks.
Matías-Guiu J; Dávalos A; Picó M; Monasterio J; Vilaseca J; Codina A
Acta Neurol Scand; 1987 Dec; 76(6):413-21. PubMed ID: 3324618
[TBL] [Abstract][Full Text] [Related]
9. The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group.
Lancet; 1987 Dec; 2(8572):1351-4. PubMed ID: 2890951
[TBL] [Abstract][Full Text] [Related]
10. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Diener HC; Cunha L; Forbes C; Sivenius J; Smets P; Lowenthal A
J Neurol Sci; 1996 Nov; 143(1-2):1-13. PubMed ID: 8981292
[TBL] [Abstract][Full Text] [Related]
11. European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderly.
Sivenius J; Riekkinen PJ; Laakso M; Smets P; Lowenthal A
Acta Neurol Scand; 1993 Feb; 87(2):111-4. PubMed ID: 8442393
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes.
Sivenius J; Riekkinen PJ; Laakso M
BMJ; 1995 Jan; 310(6971):25-6. PubMed ID: 7827549
[No Abstract] [Full Text] [Related]
13. [Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].
De Schryver EL; Gorter JW; Algra A; van Gijn J
Rev Med Interne; 1999 May; 20(5):397-9. PubMed ID: 10365408
[No Abstract] [Full Text] [Related]
14. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
[TBL] [Abstract][Full Text] [Related]
15. Dipyridamole plus aspirin in cerebrovascular disease.
Wilterdink JL; Easton JD
Arch Neurol; 1999 Sep; 56(9):1087-92. PubMed ID: 10488809
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke.
Puranen J; Laakso M; Riekkinen PJ; Sivenius J
J Cardiovasc Pharmacol; 1998 Aug; 32(2):291-4. PubMed ID: 9700992
[TBL] [Abstract][Full Text] [Related]
17. European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.
Sivenius J; Laakso M; Riekkinen P; Smets P; Lowenthal A
Stroke; 1992 Jun; 23(6):851-4. PubMed ID: 1595104
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials.
Sze PC; Reitman D; Pincus MM; Sacks HS; Chalmers TC
Stroke; 1988 Apr; 19(4):436-42. PubMed ID: 3284017
[TBL] [Abstract][Full Text] [Related]
19. Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study.
Forbes CD
Thromb Res; 1998 Sep; 92(1 Suppl 1):S1-6. PubMed ID: 9781830
[TBL] [Abstract][Full Text] [Related]
20. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
